昭衍新药:拟斥资不超800万元参与投资基金

金融界
20 Dec 2024

金融界12月20日消息,昭衍新药“公告称,”公司或其指定子公司拟作为北脑一期(北京)股权投资中心的有限合伙人,认缴出资不超过800万元人民币,参与投资该基金。该基金计划以脑科学为切入点,主要投资新一代神经系统疾病诊断与治疗等领域。截至公告日,公司尚未与相关各方签署《合伙协议》,基金尚处于筹备阶段,能否顺利完成备案及完成时间存在不确定性。由于股权投资基金投资周期较长,本次投资可能面临较长的投资回收期...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10